Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Current Opinion in Virology|August 31, 2021
Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targetsAsmaa Hachim, Niloufar Kavian, Sophie A ValkenburgClinical & Translational Immunology|June 17, 2021
Repeated influenza vaccination provides cumulative protection from distinct H3N2 virusesNiloufar Kavian, Asmaa Hachim, Benjamin J Cowling, et al.Vaccine|July 29, 2020
Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infectionNiloufar Kavian, Asmaa Hachim, Leo L M Poon, et al.Emerging Infectious Diseases|September 24, 2021
Postmortem Stability of SARS-CoV-2 in Mouse Lung TissueSophie A Valkenburg, Samuel M S Cheng, Asmaa Hachim, et al.Frontiers in Medicine|January 10, 2022
T Cells Targeting SARS-CoV-2: By Infection, Vaccination, and Against Future VariantsThi H O Nguyen, Carolyn A Cohen, Louise C Rowntree, et al.Developmental Cell|September 8, 2023
Usp25-Erlin1/2 activity limits cholesterol flux to restrict virus infectionQi Wen Teo, Ho Him Wong, Tiaan Heunis, et al.Clinical & Translational Immunology|February 7, 2020
Assessment of enhanced influenza vaccination finds that FluAd conveys an advantage in mice and older adultsNiloufar Kavian, Asmaa Hachim, Athena Py Li, et al.Nature Immunology|August 19, 2020
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infectionAsmaa Hachim, Niloufar Kavian, Carolyn A Cohen, et al.Medrxiv : the Preprint Server for Health Sciences|March 3, 2021
The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in childrenAsmaa Hachim, Haogao Gu, Otared Kavian, et al.Nature Immunology|August 29, 2020
Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infectionAsmaa Hachim, Niloufar Kavian, Carolyn A Cohen, et al.Pageof 2